calendar
7,989 catalysts · 5,347 phase readout · 2,296 8k filing · 343 pdufa · 257 earnings · 2 approval · 1 adcom
7,989 catalysts · 5,347 phase readout · 2,296 8k filing · 343 pdufa · 257 earnings · 2 approval · 1 adcom
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 3.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 1.01, 2.02, 7.01, 9.01
Items: 8.01
Items: 2.02, 5.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 3.02, 9.01
Items: 2.02
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 3.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 3.02, 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 9.01
Items: 1.02
Items: 5.02
Items: 2.03, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 5.02, 8.01, 9.01
Items: 7.01, 9.01
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 8.01, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01